Organon to Acquire Dermavant including its Innovative …
WEB2 days ago · VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional indication to treat atopic dermatitis Proposed acquisition extends Organon’s international dermatology capabilities to the U.S. JERSEY CITY, N.J., September 18, 2024 – Organon (NYSE: OGN), a global healthcare company with a mission to improve ...
News - Organon
WEBAug 6, 2024 · News. Browse our latest press releases to find more about Organon’s latest news.
Organon makes $1.2bn play for Roivant’s immuno-dermatology …
WEB1 day ago · In this article: Organon is set to acquire Roivant’s immuno-dermatology subsidiary Dermavant in a potential $1.2bn deal. Organon will pay $175m upfront for the business as part of the ...
Organon to Acquire Dermavant including its Innovative …
WEB2 days ago · JERSEY CITY, N.J., September 18, 2024--Organon enters agreement to acquire Dermavant including innovative VTAMA (tapinarof) cream, 1%, a novel, non-steroidal topical dermatologic therapy.
Organon Issues 2023 ESG Report, Highlighting Strides in …
WEB3 days ago · JERSEY CITY, N.J. – September 17, 2024 – Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today released its 2023 Environmental, Social and Governance (ESG) Report . Central to its mission to advance the health of women, the company focuses its ESG efforts on three core areas: Advancing Her Equity , innovating to support and expand access to women’s ...
Organon & Co. (OGN) Latest Stock News & Headlines - Yahoo …
WEBGet the latest Organon & Co. (OGN) stock news and headlines to help you in your trading and investing decisions.
Organon To Report Second Quarter 2024 Results and Host …
WEBJul 9, 2024 · JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EDT.
Assessing Organon’s Strategic Acquisition of ... - Markets Insider
WEB2 days ago · Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women’s health, biosimilars, and ...
Merck Announces Completion of Organon & Co. Spinoff
WEBJun 3, 2021 · “Today marks a significant milestone for both Merck and Organon. Organon is now an independent, publicly traded company with a broad portfolio of important medicines and products, and is fully prepared to deliver sustainable growth and value,” said Rob Davis, president, Merck.
Organon to Buy Roivant's Dermavant Unit in Deal Worth Up to …
WEB3 days ago · Organon on Wednesday said it will make an up-front payment of $175 million, along with up to $1.025 billion in milestone payments. ... Dow Jones Newswires is a market-moving financial and business ...